WallStreetZenWallStreetZen

NASDAQ: FWBI
First Wave Biopharma Inc Earnings & Revenue

FWBI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$15.9M
Current Profit Margin
0%

FWBI Return on Equity

Current Company
-661.8%
Current Industry
15.4%
Current Market
-8.4%
FWBI's Return on Equity (-661.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FWBI announces earnings.

FWBI Return on Assets

Current Company
-299.8%
Current Industry
2.2%
FWBI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FWBI Return on Capital Employed

Current Company
-454.56%
Current Industry
17.7%
FWBI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FWBI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FWBI$0.00-$15.63M-$15.91MN/AN/A
PCSA$0.00-$21.45M-$21.73MN/AN/A
ONCO$0.00-$17.79M-$18.28MN/AN/A
BPTH$0.00-$15.90M-$16.08MN/AN/A
CYCC$420.00k-$25.52M-$22.76M+22.87%N/A

FWBI earnings dates

Next earnings date
May 12, 2024

First Wave Biopharma Earnings & Revenue FAQ

What were FWBI's earnings last quarter?

On Invalid Date, First Wave Biopharma (NASDAQ: FWBI) reported Q3 2023 earnings per share (EPS) of -$9.20, up 102.49% year over year. Total First Wave Biopharma earnings for the quarter were -$3.48 million. In the same quarter last year, First Wave Biopharma's earnings per share (EPS) was $370.20.

If you're new to stock investing, here's how to buy First Wave Biopharma stock.

What was FWBI's earnings growth in the past year?

As of Q1 2024, First Wave Biopharma's earnings has grown year over year. First Wave Biopharma's earnings in the past year totalled -$15.91 million.

What is FWBI's earnings date?

First Wave Biopharma's earnings date is Invalid Date. Add FWBI to your watchlist to be reminded of FWBI's next earnings announcement.

What was FWBI's revenue last quarter?

On Invalid Date, First Wave Biopharma (NASDAQ: FWBI) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, First Wave Biopharma's revenue was $0.00.

What was FWBI's revenue growth in the past year?

As of Q1 2024, First Wave Biopharma's revenue has grown null year over year. First Wave Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.